BIO-key International Inc. (NASDAQ:BKYI) Short Interest Down 78.5% in August

BIO-key International Inc. (NASDAQ:BKYI) was the recipient of a significant decline in short interest in August. As of August 14th, there was short interest totaling 13,765 shares, a decline of 78.5% from the July 30th total of 63,876 shares. Currently, 1.0% of the company’s stock are short sold. Based on an average trading volume of 111,165 shares, the days-to-cover ratio is currently 0.1 days.

Analysts Set New Price Targets

Several brokerages have weighed in on BKYI. Zacks Research upgraded BIO-key International to a “hold” rating in a research note on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a report on Friday, July 17th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, BIO-key International currently has a consensus rating of “Reduce”.

Institutional Inflows and Outflows

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC increased its position in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the period. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. Institutional investors and hedge funds own 26.51% of the company’s stock.

BIO-key International Trading Up 1.7%

Shares of NASDAQ BKYI opened at $3.02 on Wednesday. The business has a 50-day moving average of $4.20 and a 200-day moving average of $5.05. The firm has a market capitalization of $4.35 million, a price-to-earnings ratio of -0.73 and a beta of 0.44. BIO-key International has a 12 month low of $2.88 and a 12 month high of $19.70.

BIO-key International (NASDAQ:BKYI) last issued its earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.82) by $0.26. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%.The business had revenue of $1.92 million during the quarter, compared to analyst estimates of $1.80 million. On average, analysts predict that BIO-key International will post -1.62 earnings per share for the current year.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.